Clinical Trial

Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel Occlusion

Study acronym: IMPACT-LVO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to describe the local change in interleukin-6 (IL-6) across a blood clot in adults with acute ischemic stroke caused by anterior circulation large vessel occlusion who are undergoing mechanical thrombectomy. The main questions it aims to answer are: * Is the level of IL-6 different in arterial blood collected beyond the clot compared with arterial blood collected before the clot during mechanical thrombectomy? * Is the trans-thrombus IL-6 difference associated with functional independence 90 days after stroke and with complications related to reperfusion injury? There is no comparison group and no experimental treatment. Researchers will compare paired blood samples collected from opposite sides of the clot in the same participant. Blood collected from a peripheral vein at hospital admission will be used only as a supportive reference for systemic inflammation. Participants will: * Receive standard mechanical thrombectomy and stroke care determined by their treating clinical team. * Have small blood samples collected at planned time points, including paired arterial blood samples collected during the thrombectomy procedure. * Have clinical and imaging information collected from their medical records and have functional status assessed 90 days after stroke. The study will not delay or change standard stroke treatment.
Trial Details
NCT Number NCT07754942
Lead Sponsor Zhongshan Hospital Xiamen University
Conditions Acute Ischemic Stroke, Large Vessel Occlusion
Enrollment 50 participants
Start Date 2026-08-01
Primary Completion 2028-08-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-10